• Issue

    Cancer Science: Volume 104, Issue 1

    January cover, i-iii, 1-142
    January 2013
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

COVER IMAGE

Free Access

MiR-150 regulates the EMT-inducer ZEB1 in esophageal squamous cell carcinoma. Wound healing assays of premiR-150-treated esophageal squamous cell carcinoma TE-8 cells

Takehiko Yokobori,  Shigemasa Suzuki,  Naritaka Tanaka,  Takanori Inose,  Makoto Sohda,  Akihiko Sano,  Makoto Sakai,  Masanobu Nakajima,  Tatsuya Miyazaki,  Hiroyuki Kato,  Hiroyuki Kuwano, 
  • Page: January cover
  • First Published: 10 January 2013

PRELIMINARY PAGE

Free Access

Preliminary Page

  • Pages: i-ii
  • First Published: 10 January 2013

In This Issue

Free Access

In This Issue

  • Page: iii
  • First Published: 11 December 2012

REVIEW ARTICLES

Free Access

Genetic factors related to gastric cancer susceptibility identified using a genome-wide association study

Norihisa Saeki,  Hiroe Ono,  Hiromi Sakamoto,  Teruhiko Yoshida, 
  • Pages: 1-8
  • First Published: 12 October 2012
Free Access

Diabetes mellitus and cancer risk: Review of the epidemiological evidence

Kentaro Shikata,  Toshiharu Ninomiya,  Yutaka Kiyohara, 
  • Pages: 9-14
  • First Published: 15 October 2012
Free Access

Next-generation peptide vaccines for advanced cancer

Akira Yamada,  Tetsuro Sasada,  Masanori Noguchi,  Kyogo Itoh, 
  • Pages: 15-21
  • First Published: 27 October 2012
Free Access

Bacillus Calmette–Guerin (BCG) immunotherapy for bladder cancer: Current understanding and perspectives on engineered BCG vaccine

Koji Kawai,  Jun Miyazaki,  Akira Joraku,  Hiroyuki Nishiyama,  Hideyuki Akaza, 
  • Pages: 22-27
  • First Published: 26 November 2012
Free Access

Epithelial mesenchymal transition from a natural gestational orchestration to a bizarre cancer disturbance

Reza Shirkoohi, 
  • Pages: 28-35
  • First Published: 26 November 2012

ORIGINAL ARTICLES

CARCINOGENESIS

Free to Read

Decreasing stearoyl-CoA desaturase-1 expression inhibits β-catenin signaling in breast cancer cells

Daniel Mauvoisin,  Cyndia Charfi,  Amine M Lounis,  Eric Rassart,  Catherine Mounier, 
  • Pages: 36-42
  • First Published: 26 September 2012

CELL, MOLECULAR, AND STEM CELL BIOLOGY

Free to Read

Detection of N-glycolyated gangliosides in non-small-cell lung cancer using GMR8 monoclonal antibody

Nobuyoshi Hayashi,  Hirofumi Chiba,  Koji Kuronuma,  Shinji Go,  Yoshihiro Hasegawa,  Motoko Takahashi,  Shinsei Gasa,  Atsushi Watanabe,  Tadashi Hasegawa,  Yoshio Kuroki,  Jinichi Inokuchi,  Hiroki Takahashi, 
  • Pages: 43-47
  • First Published: 24 September 2012
Free to Read

MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1

Takehiko Yokobori,  Shigemasa Suzuki,  Naritaka Tanaka,  Takanori Inose,  Makoto Sohda,  Akihiko Sano,  Makoto Sakai,  Masanobu Nakajima,  Tatsuya Miyazaki,  Hiroyuki Kato,  Hiroyuki Kuwano, 
  • Pages: 48-54
  • First Published: 26 September 2012
Free to Read

Implication of 14-3-3ε and 14-3-3θ/τ in proteasome inhibition-induced apoptosis of glioma cells

Ying Yan,  Ying Xu,  Yan-Yan Gao,  Zhi-Hong Zong,  Qiang Zhang,  Chao Li,  Hua-Qin Wang, 
  • Pages: 55-61
  • First Published: 29 September 2012
Free to Read

HMMC-1, a human monoclonal antibody to fucosylated core 1 O-glycan, suppresses growth of uterine endometrial cancer cells

Fumiko Oikawa,  Kyoko Kojima-Aikawa,  Fumika Inoue,  Atsushi Suzuki,  Kyoko Tanaka,  Eiichiro Tominaga,  Daisuke Aoki, 
  • Pages: 62-69
  • First Published: 05 October 2012
Free to Read

Small ubiquitin-like modifier 1–3 is activated in human astrocytic brain tumors and is required for glioblastoma cell survival

Wei Yang,  Liangli Wang,  Gabriele Roehn,  Robert D. Pearlstein,  Francis Ali-Osman,  Hongjie Pan,  Roland Goldbrunner,  Matthew Krantz,  Christoph Harms,  Wulf Paschen, 
  • Pages: 70-77
  • First Published: 19 October 2012

Free to Read

Subpopulation of small-cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy

Toshio Kubo,  Nagio Takigawa,  Masahiro Osawa,  Daijiro Harada,  Takashi Ninomiya,  Nobuaki Ochi,  Eiki Ichihara,  Hiromichi Yamane,  Mitsune Tanimoto,  Katsuyuki Kiura, 
  • Pages: 78-84
  • First Published: 16 October 2012

CLINICAL RESEARCH

Free to Read

Clinicopathological significance of MAML2 gene split in mucoepidermoid carcinoma

Haruna Noda,  Yoshihide Okumura,  Takahisa Nakayama,  Satoru Miyabe,  Yukio Fujiyoshi,  Hideo Hattori,  Kazuo Shimozato,  Hiroshi Inagaki, 
  • Pages: 85-92
  • First Published: 05 October 2012
Free to Read

Long-term results of concurrent chemoradiotherapy using cisplatin and vinorelbine for stage III non-small-cell lung cancer

Hidehito Horinouchi,  Ikuo Sekine,  Minako Sumi,  Kazumasa Noda,  Koichi Goto,  Kiyoshi Mori,  Tomohide Tamura, 
  • Pages: 93-97
  • First Published: 24 September 2012
Free to Read

Phase I trial of OTS11101, an anti-angiogenic vaccine targeting vascular endothelial growth factor receptor 1 in solid tumor

Hidetoshi Hayashi,  Takayasu Kurata,  Yasuhito Fujisaka,  Hisato Kawakami,  Kaoru Tanaka,  Takafumi Okabe,  Masayuki Takeda,  Taroh Satoh,  Koji Yoshida,  Takuya Tsunoda,  Tokuzo Arao,  Kazuto Nishio,  Kazuhiko Nakagawa, 
  • Pages: 98-104
  • First Published: 29 September 2012
Free to Read

Phase I study of obinutuzumab (GA101) in Japanese patients with relapsed or refractory B-cell non-Hodgkin lymphoma

Michinori Ogura,  Kensei Tobinai,  Kiyohiko Hatake,  Toshiki Uchida,  Tatsuya Suzuki,  Yukio Kobayashi,  Masakazu Mori,  Yasuhito Terui,  Masahiro Yokoyama,  Tomomitsu Hotta, 
  • Pages: 105-110
  • First Published: 09 October 2012
Free to Read

Phase II study of preoperative chemoradiation with S-1 plus oxaliplatin in patients with locally advanced rectal cancer

Eun Mi Lee,  Yong Sang Hong,  Kyu-pyo Kim,  Jae-Lyun Lee,  Sun Young Kim,  Young Suk Park,  Doo Ho Choi,  Jong Hoon Kim,  Seok-Byung Lim,  Chang Sik Yu,  Jin Cheon Kim,  Ju Hee Lee,  Ah Young Kim,  Tae Won Kim, 
  • Pages: 111-115
  • First Published: 12 October 2012
Free to Read

Safety, compliance, and predictive parameters for dosage modification in adjuvant S-1 chemotherapy for gastric cancer

Su-Jung Kim,  Yu Jung Kim,  Jee Hyun Kim,  Do Joong Park,  Hyung-Ho Kim,  Jong Seok Lee,  Keun-Wook Lee, 
  • Pages: 116-123
  • First Published: 16 October 2012
Free to Read

Immunotherapeutic benefit of α-interferon (IFNα) in survivin2B-derived peptide vaccination for advanced pancreatic cancer patients

Hidekazu Kameshima,  Tetsuhiro Tsuruma,  Goro Kutomi,  Hiroaki Shima,  Yuji Iwayama,  Yasutoshi Kimura,  Masahumi Imamura,  Toshihiko Torigoe,  Akari Takahashi,  Yoshihiko Hirohashi,  Yasuaki Tamura,  Tomohide Tsukahara,  Takayuki Kanaseki,  Noriyuki Sato,  Koichi Hirata, 
  • Pages: 124-129
  • First Published: 19 October 2012
Free to Read

Early response and local control of stage I non-small-cell lung cancer after stereotactic radiotherapy: difference by histology

Akifumi Miyakawa,  Yuta Shibamoto,  Katsura Kosaki,  Chisa Hashizume, 
  • Pages: 130-134
  • First Published: 25 October 2012

GENETICS, GENOMICS AND PROTEOMICS

Free to Read

Comparative proteomic study for profiling differentially expressed proteins between Chinese left- and right-sided colon cancers

Hong Shen,  Jinlin Huang,  Haiping Pei,  Shan Zeng,  Yiming Tao,  Liangfang Shen,  Liang Zeng,  Hong Zhu, 
  • Pages: 135-141
  • First Published: 24 September 2012

Correction

Free Access

Correction

  • Page: 142
  • First Published: 10 January 2013